Published on 11 Jan 2022 on MSN News
AstraZeneca (AZN) Inks Deal to Develop ATTR-CM Candidate
AstraZeneca PLC’s AZN newly acquired subsidiary, Alexion, has in-licensed rights to develop,...
NASDAQ.IPHA price evolution
NASDAQ.FGEN price evolution
NASDAQ.RPRX price evolution
NASDAQ.AZN price evolution
Want to become a better investor?
Start tracking your investments with Statfolio
Sign up for free